C4X Discovery Holdings plc
(“C4XD” or the “Company”)
Result of General Meeting
Issue of Equity
31 March 2017 – C4X Discovery Holdings plc (AIM: C4XD), a pioneering drug discovery company, today announces that, at the General Meeting held earlier today in respect of its £7.0m Placing at a Placing Price of 85 pence per new Ordinary Share, which was announced to the market on 14 March 2017, all the resolutions put to shareholders were duly passed.
Application has been made for the 8,235,294 Placing Shares to be admitted to trading on AIM and it is expected that Admission will take place at 8.00 a.m. on 3 April 2017. The Placing Shares will rank pari passu with the existing Ordinary Shares.
Following Admission, the Company's issued share capital will consist of 45,634,012 Ordinary Shares. There are no Ordinary Shares held in treasury. Therefore, in accordance with the FCA's Disclosure and Transparency Rule 5.6.1, the Company confirms that following Admission, the total number of voting rights in the Company will be 45,634,012.
The capitalised terms used in this announcement have the meaning as defined in the announcement published by the Company at 7.00 a.m. on 14 March 2017 unless otherwise stated.